Researchers developed a detailed methodology for studying how short regulatory peptides like Semax interact with brain cells at the molecular level, using radioactive tracers to track binding behavior. Semax was found to modulate the binding of acetylcholine and GABA — two key brain signaling molecules — to their receptors in a dose-dependent way, and these effects were also observed in rats recovering from stress-induced cognitive disruption. The study provides a framework for better understanding how peptides with multiple targets exert their effects.
Vyunova, Tatiana V; Andreeva, Lioudmila A; Shevchenko, Konstantin V; Myasoedov, Nikolai F